{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:13:09Z","timestamp":1792789989963,"version":"4.5.0"},"reference-count":6,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"INSERM","id":[{"id":"https:\/\/ror.org\/02vjkv261","id-type":"ROR","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/02vjkv261","id-type":"ROR","asserted-by":"publisher"}]},{"name":"CNRS"},{"name":"Toulouse University"},{"name":"Infinity"},{"id":[{"id":"https:\/\/ror.org\/00n90tt57","id-type":"ROR","asserted-by":"publisher"}]},{"name":"D\u00e9fi Cl\u00e9 Cell Based Biotherapies Occitanie"},{"name":"Occitanie Region"},{"name":"association \u201cDes \u00e9toiles dans la mer, vaincre le glioblastome\u201d, the foundation \u201cFONROGA\u201d"},{"name":"association \u201cEva pour la vie\u201d, the association \u201cRapha\u00ebl Coeur Chocolat\u201d"},{"name":"association \u201c111 Des Arts, Toulouse\u201d"},{"name":"Ligue contre le cancer","id":[{"id":"https:\/\/ror.org\/00rkrv905","id-type":"ROR","asserted-by":"crossref"}]},{"name":"foundation \u201cFlavien\u201d"},{"name":"federation \u201cGrandir sans cancer\u201d"},{"name":"\u201cAssociation pour la Recherche sur les Tumeurs C\u00e9r\u00e9brales\u201d"},{"name":"Limoges University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Human cytomegalovirus (HCMV) remains one of the most clinically significant human pathogens, representing a major cause of congenital infection worldwide and a serious threat to immunocompromised individuals, including transplant recipients and HIV\/AIDS patients [...]<\/jats:p>","DOI":"10.3390\/pathogens15090997","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:56:41Z","timestamp":1790099801000},"page":"997","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Molecular Pathogenesis to Therapeutic Innovations in Human Cytomegalovirus Research"],"prefix":"10.3390","volume":"15","author":[{"given":"Alexia","family":"Damour","sequence":"first","affiliation":[{"name":"Universit\u00e9 Limoges, Inserm, CHU Limoges, UMR 1092, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Larribau","sequence":"additional","affiliation":[{"name":"Univ Toulouse, INSERM, CNRS, Infinity - Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1237-1936","authenticated-orcid":false,"given":"Ga\u00ebtan","family":"Ligat","sequence":"additional","affiliation":[{"name":"Univ Toulouse, INSERM, CNRS, Infinity - Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Connors, G.M., and Spencer, J.V. (2025). Exploring pUS27: Insights into Its Role in HCMV Pathogenesis and Potential for Antiviral Strategies. Pathogens, 14.","DOI":"10.3390\/pathogens14100993"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zavaglio, F., Zelini, P., Cera, A., d\u2019Angelo, P., Gregorini, M., Rampino, T., Del Frate, L., Meloni, F., Borsani, O., and Pellegrini, C. (2026). Antigenic-Specificity and Cytokine Profile of the T-Cell Response to Human Cytomegalovirus in Transplant Recipients. Pathogens, 15.","DOI":"10.3390\/pathogens15010053"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Liu, F., Zou, Y., Yang, M., Zhang, J., Ohno-Matsui, K., and Kamoi, K. (2026). Cytomegalovirus Infection of the Anterior Segment: Corneal Endotheliitis and Secondary Glaucoma. Pathogens, 15.","DOI":"10.3390\/pathogens15040371"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Waters, S., Veld, L.-F., Lee, S., Hearps, A.C., Trevillyan, J., Hoy, J.F., and Price, P. (2026). An Evaluation of IL-10 Encoded by Cytomegalovirus in the Prediction of Coronary Artery Disease in People Living with HIV. Pathogens, 15.","DOI":"10.3390\/pathogens15020192"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Flores, T., Delpierre, E., Male, G., Gourin, C., Hantz, S., Damour, A., and Ligat, G. (2025). Targeting Human Cytomegalovirus as a Novel Approach for Glioblastoma Treatment. Pathogens, 14.","DOI":"10.3390\/pathogens14121291"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Murray, M.J., Hargreaves, A., Bradley, E., Lee, Q., Zhang, Y., Reuter, N., Thomas, M., and Reeves, M.B. (2026). A Potent Inhibitor of Human Cytomegalovirus Infection Works Post-Entry Specifically in Differentiating Myelo-Monocytic Cells. Pathogens, 15.","DOI":"10.3390\/pathogens15050520"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/9\/997\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:13:09Z","timestamp":1790136789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/9\/997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":6,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["pathogens15090997"],"URL":"https:\/\/doi.org\/10.3390\/pathogens15090997","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}